Community Perspectives on iPrEP Research: An Interactive Discussion of Issues & Opinions
This
teleconference is a continuation of the
intermittent pre-exposure
prophylaxis (iPrEP) conversation being
organized by the Research
Working Group of the PrEP Committee.
It was designed to
provide a forum for community members to
express their thoughts and
opinions on iPrEP research. To learn more,
about iPrEP and where to
get background information, read our Advocates'
Network announcement on this
teleconference.
Listen
to the Community Perspectives on iPrEP
Research: An Interactive Discussion of Issues
& Opinions
Agenda
PrEP
Updates: DSMB Reviews & Report-Back from
amfAR/AVAC iPrEP Workshop
Mitchell Warren, Executive Director, AVAC
Key
Questions About iPrEP
Research: What Is Your Perspective?
Jeff McConnell, Co-Investigator,
Grant Laboratory,
Epidemiology and Clinical Studies, Gladstone
Institute of Virology and
Immunology, University of California San
Francisco (UCSF)
See
the
i-PrEP Discussion Questions that Jeff has
drafted for
consideration before the call.
Advocacy Issues in
iPrEP
Research: Is Current Research and Planning
Adequate?
Chris Collins, Vice President and
Director, Public Policy,
amfAR, The Foundation for AIDS Research




